Align Technology (ALGN) FDA Approvals $168.24 -4.22 (-2.45%) Closing price 07/23/2026 04:00 PM EasternExtended Trading$168.10 -0.14 (-0.08%) As of 07/23/2026 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share FDA Events Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Align Technology's Drug in the FDA Approval ProcessThis section highlights FDA-related milestones and regulatory updates for drugs developed by Align Technology (ALGN). Over the past two years, Align Technology has reported clinical trial outcomes, regulatory submissions, approvals, and other FDA events for drugs and therapies such as Invisalign. For definitions of regulatory abbreviations such as NDA, BLA, or PDUFA, see the event status legend. Invisalign Smile Architect™ FDA Regulatory Events Invisalign Smile Architect™ is a drug developed by Align Technology for the following indication: Multiple Treatment Plans allowing doctors to visually compare and modify orthodontic only and ortho restorative treatment plans side-by-side. This drug is under review by the U.S. Food and Drug Administration (FDA). Below is a timeline of key regulatory milestones for this therapy. Highlights - May 21,2026Highlights Drug: Invisalign Smile Architect™Announced Date: May 21, 2026Indication: Multiple Treatment Plans allowing doctors to visually compare and modify orthodontic only and ortho restorative treatment plans side-by-side.AnnouncementAlign Technology, Inc today shared highlights of its 2026 Invisalign® EMEA Ortho Summit, which brought together approximately 400 orthodontists and dental professionals from across Europe, the Middle East, and Africa (EMEA).AI SummaryAlign Technology said its 2026 Invisalign EMEA Ortho Summit brought together about 400 orthodontists and dental professionals in Barcelona, Spain. The three-day event focused on the company’s next-generation digital tools for treating complex cases in kids, teens, and adults, including Class II malocclusions. Attendees got a hands-on look at the Align Innovation Hub, which showed a full digital patient journey from consultation to treatment and retention. The summit also featured doctor-led sessions on difficult cases, digital workflow improvement, and patient engagement. Align said the event highlighted how its digital platform can connect scanning, treatment planning, appliance production, monitoring, and retention into one system. The company said these tools are meant to improve treatment precision, save time for practices, and make care easier for patients.Read Announcement Align Technology FDA Events - Frequently Asked Questions Has Align Technology received FDA approval? As of now, Align Technology (ALGN) has not received any FDA approvals for its therapy in the last two years. What drugs has Align Technology submitted to the FDA? In the past two years, Align Technology (ALGN) has reported FDA regulatory activity for Invisalign Smile Architect™. What is the most recent FDA event for Align Technology? The most recent FDA-related event for Align Technology occurred on May 21, 2026, involving Invisalign Smile Architect™. The update was categorized as "Highlights," with the company reporting: "Align Technology, Inc today shared highlights of its 2026 Invisalign® EMEA Ortho Summit, which brought together approximately 400 orthodontists and dental professionals from across Europe, the Middle East, and Africa (EMEA)." What conditions do Align Technology's current drugs treat? Currently, Align Technology has one therapy (Invisalign Smile Architect™) targeting the following condition: Multiple Treatment Plans allowing doctors to visually compare and modify orthodontic only and ortho restorative treatment plans side-by-side.. More FDA Event Resources from MarketBeat FDA Calendars Recent FDA Drug Approval Calendar Upcoming FDA Events & PDUFA Dates Calendar Companies With Recent FDA Events Beam Therapeutics FDA EventsGenmab A/S FDA EventsHCW Biologics FDA EventsInhibikase Therapeutics FDA EventsIncannex Healthcare FDA EventsLantern Pharma FDA EventsJohnson & Johnson FDA EventsEli Lilly and Company FDA EventsArrowhead Pharmaceuticals FDA EventsBridgeBio Pharma FDA EventsCuris FDA EventsGreenwich LifeSciences FDA EventsLB Pharmaceuticals FDA EventsMonopar Therapeutics FDA EventsRadiopharm Theranostics FDA Events FDA Event Stage Terminology & Abbreviation Guide NDA: New Drug Application ANDA: Abbreviated New Drug Application sNDA: Supplemental New Drug Application BLA: Biologics License Application sBLA: Supplemental Biologics License Application FDA Approved: Approved by the FDA EMA: European Medicines Agency CE Mark: European Union Certification NMPA: China National Medical Products Administration MHLW: Japanese Ministry of Health FDA Meeting: Consultation with FDA Pre-IND: Pre-Investigational New Drug Meeting Breakthrough Therapy: Special FDA designation for promising therapies Fast Track: Accelerated FDA approval pathway Orphan Drug: Designation for rare disease treatments RPD: Rare Pediatric Disease Designation RMAT: Regenerative Medicine Advanced Therapy DSMB Review: Data Safety Monitoring Board Review IDMC Review: Independent Data Monitoring Committee MAA: MHRA Marketing Authorization Application RTF: Refusal to File (Rejected Application) 510(k): FDA Clearance for Medical Devices Rolling Submission: Staggered regulatory review process Related Companies DexCom FDA Events Quanterix FDA Events Cardinal Health FDA Events Haemonetics FDA Events Merit Medical Systems FDA Events QuidelOrtho FDA Events Anika Therapeutics FDA Events Becton, Dickinson and Company FDA Events Alnylam Pharmaceuticals FDA Events Revolution Medicines FDA Events Stock Lists Biotechnology StocksCompare Biotech StocksCompare Healthcare StocksCompare Pharmaceutical StocksHealthcare and Medical Stocks FDA progress for NASDAQ:ALGN last updated on 5/22/2026 by MarketBeat.com Staff. We continuously monitor for new FDA events and market data. From Our PartnersThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredElon's next move will be bigger than the IPO – and it could happen any day nowHedge fund legend Larry Benedict - who delivered a 279% return on cash in 2025 and went on a 20-year winning s...Brownstone Research | SponsoredThe SpaceX IPO Wasn't For YouJust one mile from SpaceX's launchpad sits a small company doing something SpaceX can't - and it still trades ...Freedom Financial | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredThe $40 billion "side project" Elon buried inside SpaceXElon Musk has been quietly building a $40 billion project inside SpaceX — housed in a converted refrigerator f...The Oxford Club | SponsoredThe market told you. In writing. Early.Some trading losses are surprises. Others are scheduled months, even a year, in advance and published for free...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Align Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Align Technology With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Highlights - May 21,2026Highlights Drug: Invisalign Smile Architect™Announced Date: May 21, 2026Indication: Multiple Treatment Plans allowing doctors to visually compare and modify orthodontic only and ortho restorative treatment plans side-by-side.AnnouncementAlign Technology, Inc today shared highlights of its 2026 Invisalign® EMEA Ortho Summit, which brought together approximately 400 orthodontists and dental professionals from across Europe, the Middle East, and Africa (EMEA).AI SummaryAlign Technology said its 2026 Invisalign EMEA Ortho Summit brought together about 400 orthodontists and dental professionals in Barcelona, Spain. The three-day event focused on the company’s next-generation digital tools for treating complex cases in kids, teens, and adults, including Class II malocclusions. Attendees got a hands-on look at the Align Innovation Hub, which showed a full digital patient journey from consultation to treatment and retention. The summit also featured doctor-led sessions on difficult cases, digital workflow improvement, and patient engagement. Align said the event highlighted how its digital platform can connect scanning, treatment planning, appliance production, monitoring, and retention into one system. The company said these tools are meant to improve treatment precision, save time for practices, and make care easier for patients.Read Announcement
